Skip to content
OpenCapital
Get started

Xtant Medical Holdings XTNT Q3 2025 earnings

Reported November 10, 2025 · Before market open

Revenue$33.3MBeat by $2.5M
EPS$0.01Beat by $0.02
Revenue estimate$30.8M
EPS estimate-$0.01

Next report

Aug 12, 2026 (In 2 weeks)
Revenue estimate$24.9M
EPS estimate-$0.02

Financials

Q3 2025

Income statement

See full
Revenue$33.3M+19.0%
Gross profit$22.0M+34.9%
Operating income$2.5M+167%
Net income$1.3M+126%
EPS (diluted)$0.01+125%

Balance sheet

See full
Cash & equivalents$10.6M+50.2%
Total debt$21.2M-8.2%
Total equity$50.4M+10.2%
Total assets$106.3M+7.5%

Cash flow

See full
Operating cash flow$4.6M+368%
CapEx$430.0K-79.6%
Free cash flow$4.2M+209%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$90.85M-3.1%
Enterprise value$101.38M-7.6%
P/E51.9×—
P/S0.7×-0.1×

Profitability

See full
Gross margin62%+1.1pp
Operating margin4.8%+2.8pp
Net margin1.3%—
FCF margin3.9%+2.2pp

Returns & leverage

See full
Return on equity3.6%—
Debt / equity0.4×-0.1×
Current ratio2.2×+0.1×

Segments

By product

See full
Orthobiologics$17.1M+3.4%
Spinal Implant$10.6M-6.5%

Versus estimates

Revenue

Q1 2026$20.9MBeat by $719.7KQ4 2025$32.4MBeat by $1.6M
Q3 2025$33.3MBeat by $2.5M
Q2 2025$35.4MBeat by $4.2MQ1 2025$32.9MBeat by $1.7MQ4 2024$31.5MMiss by $282.0K

Diluted EPS

Q1 2026-$0.02Miss by $0.01Q4 2025$0.00Beat by $0.01
Q3 2025$0.01Beat by $0.02
Q2 2025$0.02Beat by $0.03Q1 2025$0.00Beat by $0.01Q4 2024-$0.02Miss by $0.01

Ask the moment Xtant Medical Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Xtant Medical Holdings report Q3 2025 earnings?
Xtant Medical Holdings (XTNT) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Xtant Medical Holdings's Q3 2025 revenue and EPS?
Xtant Medical Holdings reported revenue of $33.3M and eps of $0.01 for Q3 2025.
Did Xtant Medical Holdings beat estimates in Q3 2025?
Revenue beat the consensus estimate of $30.8M by $2.5M. EPS beat the consensus estimate of $-0.01 by $0.02.
How did Xtant Medical Holdings's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 19.0% from $27.9M a year earlier.
Where can I find Xtant Medical Holdings's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021538) and the 10-Q periodic report (0001493152-25-021512) directly on SEC EDGAR. The filing index links above go to sec.gov.